{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:09:28Z","timestamp":1787065768924,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG079269"],"award-info":[{"award-number":["RF1AG079269"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R21NS133960"],"award-info":[{"award-number":["R21NS133960"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG076289"],"award-info":[{"award-number":["F31AG076289"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG086006"],"award-info":[{"award-number":["F31AG086006"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG061357"],"award-info":[{"award-number":["U01AG061357"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG071587"],"award-info":[{"award-number":["RF1AG071587"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG075820"],"award-info":[{"award-number":["R01AG075820"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG071587"],"award-info":[{"award-number":["RF1AG071587"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG075820"],"award-info":[{"award-number":["R01AG075820"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"DOI":"10.13039\/100006528","name":"Emory University | Alzheimer's Disease Research Center, Emory University","doi-asserted-by":"publisher","award":["00100569"],"award-info":[{"award-number":["00100569"]}],"id":[{"id":"10.13039\/100006528","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS114130"],"award-info":[{"award-number":["R01NS114130"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52297-3","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T10:02:46Z","timestamp":1725962566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Entorhinal cortex vulnerability to human APP expression promotes hyperexcitability and tau pathology"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-3330","authenticated-orcid":false,"given":"Annie M.","family":"Goettemoeller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmie","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5875-4065","authenticated-orcid":false,"given":"Prateek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor J.","family":"Olah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine E.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina C.","family":"Ramelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc M.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-624X","authenticated-orcid":false,"given":"Nicholas T.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3678-6215","authenticated-orcid":false,"given":"David","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-1500","authenticated-orcid":false,"given":"Srikant","family":"Rangaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-0706","authenticated-orcid":false,"given":"Matthew J. M.","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"52297_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"52297_CR2","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T Gomez-Isla","year":"1996","unstructured":"Gomez-Isla, T. et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease. J. Neurosci. 16, 4491\u20134500 (1996).","journal-title":"J. Neurosci."},{"key":"52297_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"UA Khan","year":"2014","unstructured":"Khan, U. A. et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease. Nat. Neurosci. 17, 304\u2013311 (2014).","journal-title":"Nat. Neurosci."},{"key":"52297_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.nbd.2016.05.012","volume":"93","author":"A Kobro-Flatmoen","year":"2016","unstructured":"Kobro-Flatmoen, A., Nagelhus, A. & Witter, M. P. Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer\u2019s disease. Neurobiol. Dis. 93, 172\u2013183 (2016).","journal-title":"Neurobiol. Dis."},{"key":"52297_CR5","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","volume":"80","author":"KA Vossel","year":"2016","unstructured":"Vossel, K. A. et al. Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease. Ann. Neurol. 80, 858\u2013870 (2016).","journal-title":"Ann. Neurol."},{"key":"52297_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop, J. J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron 55, 697\u2013711 (2007).","journal-title":"Neuron"},{"key":"52297_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret, L. et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708\u2013721 (2012).","journal-title":"Cell"},{"key":"52297_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fncel.2018.00121","volume":"12","author":"S Mondragon-Rodriguez","year":"2018","unstructured":"Mondragon-Rodriguez, S., Gu, N., Manseau, F. & Williams, S. Alzheimer\u2019s Transgenic Model Is Characterized by Very Early Brain Network Alterations and beta-CTF Fragment Accumulation: Reversal by beta-Secretase Inhibition. Front Cell Neurosci. 12, 121 (2018).","journal-title":"Front Cell Neurosci."},{"key":"52297_CR9","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/cercor\/bhz016","volume":"29","author":"AL Petrache","year":"2019","unstructured":"Petrache, A. L. et al. Aberrant Excitatory-Inhibitory Synaptic Mechanisms in Entorhinal Cortex Microcircuits During the Pathogenesis of Alzheimer\u2019s Disease. Cereb. Cortex 29, 1834\u20131850 (2019).","journal-title":"Cereb. Cortex"},{"key":"52297_CR10","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/s41380-019-0483-4","volume":"25","author":"S Hijazi","year":"2020","unstructured":"Hijazi, S. et al. Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer\u2019s disease. Mol. Psychiatry 25, 3380\u20133398 (2020).","journal-title":"Mol. Psychiatry"},{"key":"52297_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-020-00393-5","volume":"15","author":"ECB Johnson","year":"2020","unstructured":"Johnson, E. C. B. et al. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer\u2019s disease mutations but not by inhibition of BACE1. Mol. Neurodegener. 15, 53 (2020).","journal-title":"Mol. Neurodegener."},{"key":"52297_CR12","doi-asserted-by":"publisher","first-page":"111577","DOI":"10.1016\/j.celrep.2022.111577","volume":"41","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Hyper-excitability of corticothalamic PT neurons in mPFC promotes irritability in the mouse model of Alzheimer\u2019s disease. Cell Rep. 41, 111577 (2022).","journal-title":"Cell Rep."},{"key":"52297_CR13","doi-asserted-by":"publisher","unstructured":"Olah, V. J. et al. Biophysical K(v)3 channel alterations dampen excitability of cortical PV interneurons and contribute to network hyperexcitability in early Alzheimer\u2019s. Elife 11, https:\/\/doi.org\/10.7554\/eLife.75316 (2022).","DOI":"10.7554\/eLife.75316"},{"key":"52297_CR14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2014.10.024","volume":"84","author":"Z Siskova","year":"2014","unstructured":"Siskova, Z. et al. Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer\u2019s disease. Neuron 84, 1023\u20131033 (2014).","journal-title":"Neuron"},{"key":"52297_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01444-0","volume":"8","author":"T Nuriel","year":"2017","unstructured":"Nuriel, T. et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology. Nat. Commun. 8, 1464 (2017).","journal-title":"Nat. Commun."},{"key":"52297_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.nbd.2017.08.015","volume":"108","author":"SL Angulo","year":"2017","unstructured":"Angulo, S. L. et al. Tau and amyloid-related pathologies in the entorhinal cortex have divergent effects in the hippocampal circuit. Neurobiol. Dis. 108, 261\u2013276 (2017).","journal-title":"Neurobiol. Dis."},{"key":"52297_CR17","doi-asserted-by":"publisher","first-page":"9712","DOI":"10.1523\/JNEUROSCI.1290-18.2018","volume":"38","author":"ES Nilssen","year":"2018","unstructured":"Nilssen, E. S. et al. Inhibitory Connectivity Dominates the Fan Cell Network in Layer II of Lateral Entorhinal Cortex. J. Neurosci. 38, 9712\u20139727 (2018).","journal-title":"J. Neurosci."},{"key":"52297_CR18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41593-020-0692-9","volume":"23","author":"D Vormstein-Schneider","year":"2020","unstructured":"Vormstein-Schneider, D. et al. Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans. Nat. Neurosci. 23, 1629\u20131636 (2020).","journal-title":"Nat. Neurosci."},{"key":"52297_CR19","doi-asserted-by":"publisher","unstructured":"Titlow, J. S. et al. Systematic analysis of YFP traps reveals common mRNA\/protein discordance in neural tissues. J. Cell Biol. 222, https:\/\/doi.org\/10.1083\/jcb.202205129 (2023).","DOI":"10.1083\/jcb.202205129"},{"key":"52297_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30623-x","volume":"13","author":"S Rayaprolu","year":"2022","unstructured":"Rayaprolu, S. et al. Cell type-specific biotin labeling in vivo resolves regional neuronal and astrocyte proteomic differences in mouse brain. Nat. Commun. 13, 2927 (2022).","journal-title":"Nat. Commun."},{"key":"52297_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47028-7","volume":"15","author":"P Kumar","year":"2024","unstructured":"Kumar, P. et al. Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer\u2019s pathology. Nat. Commun. 15, 2823 (2024).","journal-title":"Nat. Commun."},{"key":"52297_CR22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2020.1807","volume":"77","author":"L Yu","year":"2020","unstructured":"Yu, L. et al. Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons. JAMA Psychiatry 77, 1172\u20131180 (2020).","journal-title":"JAMA Psychiatry"},{"key":"52297_CR23","doi-asserted-by":"publisher","first-page":"104509","DOI":"10.1016\/j.nbd.2019.104509","volume":"130","author":"CF Mendonca","year":"2019","unstructured":"Mendonca, C. F. et al. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer\u2019s disease. Neurobiol. Dis. 130, 104509 (2019).","journal-title":"Neurobiol. Dis."},{"key":"52297_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-022-00572-6","volume":"17","author":"T Kavanagh","year":"2022","unstructured":"Kavanagh, T., Halder, A. & Drummond, E. Tau interactome and RNA binding proteins in neurodegenerative diseases. Mol. Neurodegener. 17, 66 (2022).","journal-title":"Mol. Neurodegener."},{"key":"52297_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02132-4","volume":"12","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Early impairment of cortical circuit plasticity and connectivity in the 5XFAD Alzheimer\u2019s disease mouse model. Transl. Psychiatry 12, 371 (2022).","journal-title":"Transl. Psychiatry"},{"key":"52297_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0896-6273(90)90446-M","volume":"4","author":"EH Koo","year":"1990","unstructured":"Koo, E. H. et al. Differential expression of amyloid precursor protein mRNAs in cases of Alzheimer\u2019s disease and in aged nonhuman primates. Neuron 4, 97\u2013104 (1990).","journal-title":"Neuron"},{"key":"52297_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","volume":"1161","author":"T Matsui","year":"2007","unstructured":"Matsui, T. et al. Expression of APP pathway mRNAs and proteins in Alzheimer\u2019s disease. Brain Res. 1161, 116\u2013123 (2007).","journal-title":"Brain Res."},{"key":"52297_CR28","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s11064-021-03332-y","volume":"46","author":"L Lehmann","year":"2021","unstructured":"Lehmann, L., Lo, A., Knox, K. M. & Barker-Haliski, M. Alzheimer\u2019s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation. Neurochem Res 46, 1895\u20131912 (2021).","journal-title":"Neurochem Res"},{"key":"52297_CR29","doi-asserted-by":"publisher","unstructured":"Chen, L. et al. Progressive excitability changes in the medial entorhinal cortex in the 3xTg mouse model of Alzheimer\u2019s disease pathology. bioRxiv, https:\/\/doi.org\/10.1101\/2023.05.30.542838 (2023).","DOI":"10.1101\/2023.05.30.542838"},{"key":"52297_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cne.20706","volume":"491","author":"B Tahvildari","year":"2005","unstructured":"Tahvildari, B. & Alonso, A. Morphological and electrophysiological properties of lateral entorhinal cortex layers II and III principal neurons. J. Comp. Neurol. 491, 123\u2013140 (2005).","journal-title":"J. Comp. Neurol."},{"key":"52297_CR31","doi-asserted-by":"publisher","unstructured":"Chen, L., Saito, T., Saido, T. C. & Mody, I. Novel Quantitative Analyses of Spontaneous Synaptic Events in Cortical Pyramidal Cells Reveal Subtle Parvalbumin-Expressing Interneuron Dysfunction in a Knock-In Mouse Model of Alzheimer\u2019s Disease. eNeuro 5, https:\/\/doi.org\/10.1523\/ENEURO.0059-18.2018 (2018).","DOI":"10.1523\/ENEURO.0059-18.2018"},{"key":"52297_CR32","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nn.2570","volume":"13","author":"C Varga","year":"2010","unstructured":"Varga, C., Lee, S. Y. & Soltesz, I. Target-selective GABAergic control of entorhinal cortex output. Nat. Neurosci. 13, 822\u2013824 (2010).","journal-title":"Nat. Neurosci."},{"key":"52297_CR33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1152\/jn.00722.2015","volume":"115","author":"R Gao","year":"2016","unstructured":"Gao, R. Interpreting the electrophysiological power spectrum. J. Neurophysiol. 115, 628\u2013630 (2016).","journal-title":"J. Neurophysiol."},{"key":"52297_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-7091-7508-8_9","volume":"54","author":"H Braak","year":"1998","unstructured":"Braak, H., Braak, E., Bohl, J. & Bratzke, H. Evolution of Alzheimer\u2019s disease related cortical lesions. J. Neural Transm. Suppl. 54, 97\u2013106 (1998).","journal-title":"J. Neural Transm. Suppl."},{"key":"52297_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/archneurol.2011.3354","volume":"69","author":"RS Desikan","year":"2012","unstructured":"Desikan, R. S. et al. Amyloid-beta-associated clinical decline occurs only in the presence of elevated P-tau. Arch. Neurol. 69, 709\u2013713 (2012).","journal-title":"Arch. Neurol."},{"key":"52297_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue, L. F. et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am. J. Pathol. 155, 853\u2013862 (1999).","journal-title":"Am. J. Pathol."},{"key":"52297_CR37","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","volume":"283","author":"J Naslund","year":"2000","unstructured":"Naslund, J. et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283, 1571\u20131577 (2000).","journal-title":"JAMA"},{"key":"52297_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.nbd.2018.07.003","volume":"118","author":"MK Schultz Jr.","year":"2018","unstructured":"Schultz, M. K. Jr. et al. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice. Neurobiol. Dis. 118, 161\u2013176 (2018).","journal-title":"Neurobiol. Dis."},{"key":"52297_CR39","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu, J. W. et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat. Neurosci. 19, 1085\u20131092 (2016).","journal-title":"Nat. Neurosci."},{"key":"52297_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada, K. et al. Neuronal activity regulates extracellular tau in vivo. J. Exp. Med 211, 387\u2013393 (2014).","journal-title":"J. Exp. Med"},{"key":"52297_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","volume":"22","author":"MA Busche","year":"2019","unstructured":"Busche, M. A. et al. Tau impairs neural circuits, dominating amyloid-beta effects, in Alzheimer models in vivo. Nat. Neurosci. 22, 57\u201364 (2019).","journal-title":"Nat. Neurosci."},{"key":"52297_CR42","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","volume":"29","author":"R Minkeviciene","year":"2009","unstructured":"Minkeviciene, R. et al. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J. Neurosci. 29, 3453\u20133462 (2009).","journal-title":"J. Neurosci."},{"key":"52297_CR43","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1523\/JNEUROSCI.2552-14.2015","volume":"35","author":"AM Hall","year":"2015","unstructured":"Hall, A. M. et al. Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer\u2019s disease. J. Neurosci. 35, 6221\u20136230 (2015).","journal-title":"J. Neurosci."},{"key":"52297_CR44","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","volume":"111","author":"M Colom-Cadena","year":"2023","unstructured":"Colom-Cadena, M. et al. Synaptic oligomeric tau in Alzheimer\u2019s disease - A potential culprit in the spread of tau pathology through the brain. Neuron 111, 2170\u20132183 e2176 (2023).","journal-title":"Neuron"},{"key":"52297_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fncir.2015.00020","volume":"9","author":"M Nassar","year":"2015","unstructured":"Nassar, M. et al. Diversity and overlap of parvalbumin and somatostatin expressing interneurons in mouse presubiculum. Front Neural Circuits 9, 20 (2015).","journal-title":"Front Neural Circuits"},{"key":"52297_CR46","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.celrep.2018.07.053","volume":"24","author":"AB Munoz-Manchado","year":"2018","unstructured":"Munoz-Manchado, A. B. et al. Diversity of Interneurons in the Dorsal Striatum Revealed by Single-Cell RNA Sequencing and PatchSeq. Cell Rep. 24, 2179\u20132190 e2177 (2018).","journal-title":"Cell Rep."},{"key":"52297_CR47","doi-asserted-by":"publisher","unstructured":"Ekins, T. G. et al. Emergence of non-canonical parvalbumin-containing interneurons in hippocampus of a murine model of type I lissencephaly. Elife 9, https:\/\/doi.org\/10.7554\/eLife.62373 (2020).","DOI":"10.7554\/eLife.62373"},{"key":"52297_CR48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang, Y. A., Zhou, B., Wernig, M. & Sudhof, T. C. ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Abeta Secretion. Cell 168, 427\u2013441 e421 (2017).","journal-title":"Cell"},{"key":"52297_CR49","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.stemcr.2021.07.017","volume":"16","author":"SI Lee","year":"2021","unstructured":"Lee, S. I. et al. APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Abeta generation. Stem Cell Rep. 16, 2128\u20132137 (2021).","journal-title":"Stem Cell Rep."},{"key":"52297_CR50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neulet.2005.02.014","volume":"381","author":"MK Thakur","year":"2005","unstructured":"Thakur, M. K. & Mani, S. T. Estradiol regulates APP mRNA alternative splicing in the mice brain cortex. Neurosci. Lett. 381, 154\u2013157 (2005).","journal-title":"Neurosci. Lett."},{"key":"52297_CR51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.neuint.2006.01.026","volume":"49","author":"A Bjelik","year":"2006","unstructured":"Bjelik, A. et al. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochem Int 49, 393\u2013400 (2006).","journal-title":"Neurochem Int"},{"key":"52297_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2006.07.009","volume":"50","author":"A Bjelik","year":"2007","unstructured":"Bjelik, A. et al. APP mRNA splicing is upregulated in the brain of biglycan transgenic mice. Neurochem Int 50, 1\u20134 (2007).","journal-title":"Neurochem Int"},{"key":"52297_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2042-6410-3-24","volume":"3","author":"DB Dubal","year":"2012","unstructured":"Dubal, D. B., Broestl, L. & Worden, K. Sex and gonadal hormones in mouse models of Alzheimer\u2019s disease: what is relevant to the human condition? Biol. Sex. Differ. 3, 24 (2012).","journal-title":"Biol. Sex. Differ."},{"key":"52297_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000026149","volume":"17","author":"IL Notkola","year":"1998","unstructured":"Notkola, I. L. et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u2019s disease. Neuroepidemiology 17, 14\u201320 (1998).","journal-title":"Neuroepidemiology"},{"key":"52297_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","volume":"137","author":"M Kivipelto","year":"2002","unstructured":"Kivipelto, M. et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann. Intern Med 137, 149\u2013155 (2002).","journal-title":"Ann. Intern Med"},{"key":"52297_CR56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1212\/01.WNL.0000150886.50187.30","volume":"64","author":"LS Honig","year":"2005","unstructured":"Honig, L. S., Kukull, W. & Mayeux, R. Atherosclerosis and AD: analysis of data from the US National Alzheimer\u2019s Coordinating Center. Neurology 64, 494\u2013500 (2005).","journal-title":"Neurology"},{"key":"52297_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fnagi.2017.00243","volume":"9","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. Enhanced Gamma Activity and Cross-Frequency Interaction of Resting-State Electroencephalographic Oscillations in Patients with Alzheimer\u2019s Disease. Front Aging Neurosci. 9, 243 (2017).","journal-title":"Front Aging Neurosci."},{"key":"52297_CR58","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito, T. et al. Single App knock-in mouse models of Alzheimer\u2019s disease. Nat. Neurosci. 17, 661\u2013663 (2014).","journal-title":"Nat. Neurosci."},{"key":"52297_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22624-z","volume":"12","author":"D Baglietto-Vargas","year":"2021","unstructured":"Baglietto-Vargas, D. et al. Generation of a humanized Abeta expressing mouse demonstrating aspects of Alzheimer\u2019s disease-like pathology. Nat. Commun. 12, 2421 (2021).","journal-title":"Nat. Commun."},{"key":"52297_CR60","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke, L. et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050\u20134058 (2000).","journal-title":"J. Neurosci."},{"key":"52297_CR61","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1093\/cercor\/bhaa025","volume":"30","author":"A Mehr","year":"2020","unstructured":"Mehr, A. et al. Lack of APP and APLP2 in GABAergic Forebrain Neurons Impairs Synaptic Plasticity and Cognition. Cereb. Cortex 30, 4044\u20134063 (2020).","journal-title":"Cereb. Cortex"},{"key":"52297_CR62","doi-asserted-by":"publisher","first-page":"660319","DOI":"10.3389\/fnagi.2021.660319","volume":"13","author":"K Yamamoto","year":"2021","unstructured":"Yamamoto, K., Yamamoto, R. & Kato, N. Amyloid beta and Amyloid Precursor Protein Synergistically Suppress Large-Conductance Calcium-Activated Potassium Channel in Cortical Neurons. Front Aging Neurosci. 13, 660319 (2021).","journal-title":"Front Aging Neurosci."},{"key":"52297_CR63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.yjmcc.2015.10.006","volume":"89","author":"M Agsten","year":"2015","unstructured":"Agsten, M. et al. BACE1 modulates gating of KCNQ1 (Kv7.1) and cardiac delayed rectifier KCNQ1\/KCNE1 (IKs). J. Mol. Cell Cardiol. 89, 335\u2013348 (2015).","journal-title":"J. Mol. Cell Cardiol."},{"key":"52297_CR64","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/19336950.2016.1196307","volume":"10","author":"S Lehnert","year":"2016","unstructured":"Lehnert, S. et al. Ion channel regulation by beta-secretase BACE1 - enzymatic and non-enzymatic effects beyond Alzheimer\u2019s disease. Channels (Austin) 10, 365\u2013378 (2016).","journal-title":"Channels (Austin)"},{"key":"52297_CR65","doi-asserted-by":"publisher","first-page":"23009","DOI":"10.1074\/jbc.M414648200","volume":"280","author":"HK Wong","year":"2005","unstructured":"Wong, H. K. et al. beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J. Biol. Chem. 280, 23009\u201323017 (2005).","journal-title":"J. Biol. Chem."},{"key":"52297_CR66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.33594\/000000397","volume":"55","author":"RW Manville","year":"2021","unstructured":"Manville, R. W. & Abbott, G. W. The Amyloid Precursor Protein C99 Fragment Modulates Voltage-Gated Potassium Channels. Cell Physiol. Biochem 55, 157\u2013170 (2021).","journal-title":"Cell Physiol. Biochem"},{"key":"52297_CR67","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/379074a0","volume":"379","author":"K Furukawa","year":"1996","unstructured":"Furukawa, K., Barger, S. W., Blalock, E. M. & Mattson, M. P. Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature 379, 74\u201378 (1996).","journal-title":"Nature"},{"key":"52297_CR68","doi-asserted-by":"publisher","first-page":"e0134385","DOI":"10.1371\/journal.pone.0134385","volume":"10","author":"J Mayordomo-Cava","year":"2015","unstructured":"Mayordomo-Cava, J., Yajeya, J., Navarro-Lopez, J. D. & Jimenez-Diaz, L. Amyloid-beta(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus. PLoS One 10, e0134385 (2015).","journal-title":"PLoS One"},{"key":"52297_CR69","doi-asserted-by":"publisher","first-page":"e11820","DOI":"10.1371\/journal.pone.0011820","volume":"5","author":"FJ Sepulveda","year":"2010","unstructured":"Sepulveda, F. J., Parodi, J., Peoples, R. W., Opazo, C. & Aguayo, L. G. Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 5, e11820 (2010).","journal-title":"PLoS One"},{"key":"52297_CR70","doi-asserted-by":"publisher","first-page":"e45881","DOI":"10.1371\/journal.pone.0045881","volume":"7","author":"JA Harris","year":"2012","unstructured":"Harris, J. A. et al. Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits. PLoS One 7, e45881 (2012).","journal-title":"PLoS One"},{"key":"52297_CR71","doi-asserted-by":"publisher","unstructured":"Pickett, E. K. et al. Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer\u2019s disease. Synapse 71, https:\/\/doi.org\/10.1002\/syn.21965 (2017).","DOI":"10.1002\/syn.21965"},{"key":"52297_CR72","doi-asserted-by":"publisher","first-page":"805063","DOI":"10.3389\/fnagi.2022.805063","volume":"14","author":"ZA Cope","year":"2022","unstructured":"Cope, Z. A., Murai, T. & Sukoff Rizzo, S. J. Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer\u2019s Disease. Front Aging Neurosci. 14, 805063 (2022).","journal-title":"Front Aging Neurosci."},{"key":"52297_CR73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2023.01.016","volume":"125","author":"MA Kelberman","year":"2023","unstructured":"Kelberman, M. A. et al. Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer\u2019s disease. Neurobiol. Aging 125, 98\u2013108 (2023).","journal-title":"Neurobiol. Aging"},{"key":"52297_CR74","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1523\/JNEUROSCI.0425-20.2020","volume":"40","author":"A Caccavano","year":"2020","unstructured":"Caccavano, A. et al. Inhibitory Parvalbumin Basket Cell Activity is Selectively Reduced during Hippocampal Sharp Wave Ripples in a Mouse Model of Familial Alzheimer\u2019s Disease. J. Neurosci. 40, 5116\u20135136 (2020).","journal-title":"J. Neurosci."},{"key":"52297_CR75","doi-asserted-by":"publisher","first-page":"e3000851","DOI":"10.1371\/journal.pbio.3000851","volume":"18","author":"GA Rodriguez","year":"2020","unstructured":"Rodriguez, G. A., Barrett, G. M., Duff, K. E. & Hussaini, S. A. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Abeta and tau pathology in the hippocampus. PLoS Biol. 18, e3000851 (2020).","journal-title":"PLoS Biol."},{"key":"52297_CR76","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nn.2801","volume":"14","author":"AW Bero","year":"2011","unstructured":"Bero, A. W. et al. Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat. Neurosci. 14, 750\u2013756 (2011).","journal-title":"Nat. Neurosci."},{"key":"52297_CR77","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1126\/science.164.3880.719","volume":"164","author":"JW Olney","year":"1969","unstructured":"Olney, J. W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719\u2013721 (1969).","journal-title":"Science"},{"key":"52297_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10827-011-0346-8","volume":"32","author":"AL Taylor","year":"2012","unstructured":"Taylor, A. L. What we talk about when we talk about capacitance measured with the voltage-clamp step method. J. Comput Neurosci. 32, 167\u2013175 (2012).","journal-title":"J. Comput Neurosci."},{"key":"52297_CR79","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1016\/j.neuron.2023.09.005","volume":"111","author":"KA Pelkey","year":"2023","unstructured":"Pelkey, K. A. et al. Evolutionary conservation of hippocampal mossy fiber synapse properties. Neuron 111, 3802\u20133818 e3805 (2023).","journal-title":"Neuron"},{"key":"52297_CR80","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"52297_CR81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson, E. C. B. et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat. Neurosci. 25, 213\u2013225 (2022).","journal-title":"Nat. Neurosci."},{"key":"52297_CR82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-018-0266-4","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju, S. et al. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer\u2019s disease-related proteins. Mol. Neurodegener. 13, 34 (2018).","journal-title":"Mol. Neurodegener."},{"key":"52297_CR83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-020-00377-5","volume":"15","author":"S Rayaprolu","year":"2020","unstructured":"Rayaprolu, S. et al. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer\u2019s disease. Mol. Neurodegener. 15, 28 (2020).","journal-title":"Mol. Neurodegener."},{"key":"52297_CR84","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res"},{"key":"52297_CR85","doi-asserted-by":"publisher","first-page":"105655","DOI":"10.1016\/j.nbd.2022.105655","volume":"166","author":"E Galea","year":"2022","unstructured":"Galea, E. et al. Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer\u2019s disease. Neurobiol. Dis. 166, 105655 (2022).","journal-title":"Neurobiol. Dis."},{"key":"52297_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52297-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52297-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52297-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:04:18Z","timestamp":1725966258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52297-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52297"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52297-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.11.06.565629","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-3370607\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7918"}}